October 11, 2020
Article
Cataracts, but not AMD or glaucoma, were associated with an increased risk of depressive symptoms in the elderly in a prospective long-term study.
October 08, 2020
There was also a decline depression care in recent years among adolescents and young adults.
October 01, 2020
There could be a lasting impact caused by some of the changes due to the pandemic.
This edition from the 10 Year Plan features perspective from leadership at APA and AADPRT, as well as survey results from psychiatrists.
September 28, 2020
For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.
August 26, 2020
Video
J. John Mann, MD, discusses potential next steps for further assessment of ketamine's antidepressant effects.
August 24, 2020
J. John Mann, MD, discusses findings in a new study that uncovers the mechanisms behind Ketamine's antidepressant effect.
August 21, 2020
J. John Mann, MD, compares esketamine nasal spray to intravenous administration and explains the drawbacks of the newly approved treatment method for MDD.
August 20, 2020
The majority of older adults participating in the study expressed outrage at what they deemed to be an inadequate government response to the pandemic.
August 19, 2020
J. John Mann, MD, gives a brief overview of where we are now in treatment of major depressive disorder.
